Navigation Links
Uptake Medical® Expands Executive Team, Announces European General Manager Lloyd Mencinger
Date:9/6/2011

TUSTIN, Calif., Sept. 6, 2011 /PRNewswire/ -- Uptake Medical® Corp., maker of InterVapor™, a minimally invasive treatment for severe emphysema, today announced that seasoned medical device executive Lloyd Mencinger has joined the company as European General Manager, effective September 1, 2011.

Mr. Mencinger joins Uptake Medical with nearly three decades of broad functional experience with medical device leaders such as Boston Scientific, Baxter, and American Hospital Supply and most recently with Tenent Healthcare serving as Senior Vice President of Business Development, providing him with insights into the evolving healthcare environment. His tenure with Boston Scientific included nearly 10 years living within the European Union focusing on sales, marketing, business development, operations and clinical economics & government affairs.

"It is rare to find such broad functional expertise in one individual. We are thrilled to welcome Lloyd to Uptake Medical," said King Nelson, President and CEO. "Specifically, Lloyd's extensive experience in building markets for innovative technologies, his understanding of global healthcare environments and his ability to navigate appropriate channels to secure reimbursement will be major assets as we move towards commercialization."

InterVapor is the first and only personalized endoscopic lung volume reduction procedure to use the energy of heated water vapor and the body's own healing process to target hyperinflation. With InterVapor, the diseased lung volume is reduced, giving patients with severe emphysema clinically meaningful improvement in breathing function and quality of life. This is done without implants or chemicals being placed or left behind in the delicate lung tissue.

About his appointment, Mr. Mencinger commented, "The global burden of emphysema is large and growing, and the opportunity to introduce a unique technology, such as InterVapor, to help this population of patients is truly exciting. Uptake Medical's pioneering approach to lung volume reduction is certain to help improve the quality of life for many emphysema sufferers."

About Emphysema:

Emphysema and chronic bronchitis are captured under the umbrella of Chronic Obstructive Pulmonary Disease (COPD). The Word Health Organization has stated that the incidence of COPD is on the rise, on pace to becoming the third leading cause of death by 2030. In the United States, where nearly 5 million people are diagnosed with emphysema, it already holds this position, with one person dying every 4 minutes. Debilitating and costly, nearly $50 billion was spent on the direct and indirect costs associated with COPD in the U.S. in 2010.

About Uptake Medical:

With headquarters in Tustin, Calif., Uptake Medical develops innovative medical technologies for the treatment of lung diseases. Its first product, InterVapor, is the first and only approach to endoscopic lung volume reduction for people with severe emphysema that uses the body's natural healing process without leaving any foreign materials in the lung. In clinical studies, InterVapor has demonstrated clinically meaningful improvements in breathing function, exercise capacity and quality of life. More information can be found at www.uptakemedical.com.

Uptake Medical and InterVapor are registered trademarks and trademarks of Uptake Medical.


'/>"/>
SOURCE Uptake Medical Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market
2. Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
3. Uptake Medical Announces Scott Huennekens Elected to Board of Directors
4. The Harley Medical Group Sees an Uptake in Surgery Bookings for Christmas
5. Uptake Medical Names J.C. MacRae as Chief Financial Officer
6. Driven by the Uptake of Several Emerging Agents, the MRSA Drug Market Will Increase From $631 Million in 2009 to $752 Million in 2019
7. Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015
8. The Continued Uptake of Key Agents Such as Januvia, Bydureon and Byetta Will Drive The Type 2 Diabetes Drug Market to Nearly Double From $19 Billion in 2009 to $36 Billion in 2019
9. BridgePoint Medical®, Inc. Completes and Submits to FDA in the U.S. FAST-CTOs With the CrossBoss® and Stingray® CTO Recanalization System
10. Pacira Pharmaceuticals, Inc. Expands EXPAREL™ Commercial Team Infrastructure
11. IRIDEX Expands ENT Laser Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... N.C. , March 23, 2017  Transportation Insight, ... as an end-to-end supply chain management firm with expertise ... Consumer Product Solutions Rick Zaffarano was named ... of the Supply Chain by the only publication exclusively ... global food supply chain. "Rick has brought ...
(Date:3/23/2017)... BARBARA, Calif. and INDIANAPOLIS ... (NYSE: LLY ) and the William Sansum ... the lives of Latino people affected by diabetes through ... tremendous burden of diabetes and cardiovascular disease bears a ... United States ," said David Kerr , ...
(Date:3/23/2017)...  The U.S. Food and Drug Administration today granted ... adults and pediatric patients 12 years and older with ... not received prior chemotherapy. This is the first FDA-approved ... skin cancer. "While skin cancer is one ... form called Merkel cell cancer have not had an ...
Breaking Medicine Technology:
(Date:3/24/2017)... , ... March 24, 2017 , ... The iaedp Foundation, ... other medical professionals caring for those suffering from the full spectrum of disordered eating, ... as eating disorders professionals from nearly all 50 states and several countries converged on ...
(Date:3/24/2017)... ... March 24, 2017 , ... As the ... create a communications platform that positions them as the go-to thought leader in ... their online publication as an always-on, always-fresh news, views and advocacy engine, called ...
(Date:3/24/2017)... ... ... Viewers who like to educate themselves on current issues and who enjoy ... societal issues tend to appreciate and love the "Informed" series, hosted by Rob Lowe. ... for causes around the world. , Running for charity has become a ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Finding Christ ... #TruthwithGrace”: a devotional journal chronicling the writer’s path toward true communion with God. ... with God #TruthwithGrace” is the creation of published author Lea Michelle Johnson, a ...
(Date:3/24/2017)... ... , ... “The Adventures of Joey, The Dog Who Barks at Puddles”: a ... to the fullest, as God intended. “The Adventures of Joey, The Dog Who Barks ... pursuing her passion for writing, especially about truth and human behavior. , Published by ...
Breaking Medicine News(10 mins):